MBX Biosciences Statistics
NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
49.55-3.86 (-7.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MBX Biosciences by the numbers
MBX Biosciences has a market capitalization of $2.46 billion based on 49.66M shares outstanding. With trailing EPS of $-3.03, MBX Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 6.1% above its 200-day average.
Average daily trading volume is 532.80K shares, or about $26.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
MBX valuation vs. peer median
| Metric | MBX | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.46B | $2.33B | +6% |
| Avg. volume | 532.80K | 962.46K | -45% |
Peer median across 8 companies: IDYA, XNCR, PBH, HCM, ZLAB, RCUS, PHVS, PRGO.
Valuation
- Market cap
- $2.46B
- EPS (TTM)
- $-3.03
- Shares outstanding
- 49.66M
Price and trading
- Previous close
- 53.41
- Open
- 52.92
- Day range
- 49.36 – 54.43
- 52-week range
- 26.14 – 72.64
- 52-week change
- +82.98%
- Beta
- —
- Volume
- 581.89K
- Average volume
- 532.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 2.46B
- Forward Pe
- -11.38
- Eps
- -3.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 72.64
- Week52 Low
- 26.14
- Avg Volume
- 532.80K
- Shares Outstanding
- 49.66M
- Ma50
- 54.88
- Ma200
- 46.69
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -31.79%
- Pct From52w Low
- 89.56%